The Next Variant of International Arbitration Life Sciences
Welcome to this session on the next major frontier of international arbitration: the life sciences sector. Moderated by Patrick Pierce, this panel brings together leading experts to explore how intellectual property protection, regulatory complexity, and collaboration strategies are reshaping dispute resolution in this rapidly evolving industry. The speakers discuss the challenges of valuing early-stage IP, the risks of cross-border disputes, and the impact of industrial policies on investment. They also examine the role of efforts clauses and the potential of investment treaty protections. Join us as we uncover how scientific innovation and international arbitration intersect to tackle the challenges ahead
